Hypercholesterolemia accelerates amyloid β-induced cognitive deficits

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 577-582

  Park, Sun Haeng ^a   Kim, Ji Hyun ^a   Choi, Kyung Ha ^a   Jang, Young Jung ^a   Bae, Sun Sik ^b   Choi, Byung Tae ^a   Shin, Hwa Kyoung ^a  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Amyloid ; Cognitive impairment; Hypercholesterolemia; Microglia; Phosphorylated tau

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; APOLIPOPROTEIN E; CHOLESTEROL; TAU PROTEIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; LIPID DIET; MALE; MAZE TEST; MEMORY DISORDER; MICROGLIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPATIAL LEARNING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIGENS, CD11B; APOLIPOPROTEINS E; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FOOD HABITS; HYPERCHOLESTEROLEMIA; INFLAMMATION; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICROGLIA; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS;

EID: 84873117976     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1233     Document Type: Article

References (31)

1. Solomon A and Kivipelto M: Cholesterol-modifying strategies for Alzheimer's disease. Expert Rev Neurother 9: 695-709, 2009.
2. Stefani M and Liguri G: Cholesterol in Alzheimer's disease: unresolved questions. Curr Alzheimer Res 6: 15-29, 2009.
3. Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T and Gross DR: Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126: 88-94, 1994.
4. Refolo LM, Malester B, LaFrancois J, et al: Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7: 321-331, 2000.
5. Levin-Allerhand JA, Lominska CE and Smith JD: Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J Nutr Health Aging 6: 315-319, 2002.
6. Shie FS, Jin LW, Cook DG, Leverenz JB and LeBoeuf RC: Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13: 455-459, 2002.
7. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG and Simons K: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95: 6460-6464, 1998.
8. Xue QS, Sparks DL and Streit WJ: Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production. J Neuroinflammation 4: 20, 2007.
9. Akiyama H, Barger S, Barnum S, et al: Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421, 2000.
10. Rogers J: The inflammatory response in Alzheimer's disease. J Periodontol 79 (Suppl 8): S1535-S1543, 2008.
11. Takeda S, Sato N, Niisato K, et al: Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Res 1280: 137-147, 2009.
12. Casserly I and Topol E: Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363: 1139-1146, 2004.
13. Sjogren M, Mielke M, Gustafson D, Zandi P and Skoog I: Cholesterol and Alzheimer's disease - is there a relation? Mech Ageing Dev 127: 138-147, 2006.
14. Canevari L and Clark JB: Alzheimer's disease and cholesterol: the fat connection. Neurochem Res 32: 739-750, 2007.
15. van Vliet P, van de Water W, de Craen AJ and Westendorp RG: The influence of age on the association between cholesterol and cognitive function. Exp Gerontol 44: 112-122, 2009.
16. Cedazo-Minguez A, Ismail MA and Mateos L: Plasma cholesterol and risk for late-onset Alzheimer's disease. Expert Rev Neurother 11: 495-498, 2011.
17. Ghribi O: Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. J Alzheimers Dis 15: 673-684, 2008.
18. Simons M, Keller P, Dichgans J and Schulz JB: Cholesterol and Alzheimer's disease: is there a link? Neurology 57: 1089-1093, 2001.
19. Sharma S, Prasanthi RPJ, Schommer E, Feist G and Ghribi O: Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis 32: 426-432, 2008.
20. Ghribi O, Larsen B, Schrag M and Herman MM: High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200: 460-467, 2006.
21. Fitz NF, Cronican A, Pham T, et al: Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci 30: 6862-6872, 2010.
22. Ullrich C, Pirchl M and Humpel C: Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci 45: 408-417, 2010.
23. Schreurs BG: The effects of cholesterol on learning and memory. Neurosci Biobehav Rev 34: 1366-1379, 2010.
24. Cao D, Fukuchi K, Wan H, Kim H and Li L: Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging 27: 1632-1643, 2006.
25. Evola M, Hall A, Wall T, Young A and Grammas P: Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol Biochem Behav 96: 181-186, 2010.
26. Thirumangalakudi L, Prakasam A, Zhang R, et al: High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106: 475-485, 2008.
27. Heneka MT and O'Banion MK: Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184: 69-91, 2007.
28. Perry VH, Newman TA and Cunningham C: The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 4: 103-112, 2003.
29. Yankner BA, Duffy LK and Kirschner DA: Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279-282, 1990.
30. Yamada K and Nabeshima T: Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 88: 93-113, 2000.
31. Kim DH, Kim S, Jeon SJ, et al: The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice. Neuropharmacology 55: 639-647, 2008.